Neonatal hypoglycemia, part II: pathophysiology and therapy.
Contemporary research is elucidating both the molecular mechanisms of hypoglycemia-induced neuronal injury and its corresponding clinical manifestations. Recognizing and screening those neonates at highest risk of hypoglycemia-induced injury is an important skill for all physicians responsible for the care of newborns. Appropriate therapy, consisting of either oral or intravenous glucose, should never be delayed while one is awaiting laboratory confirmation of a "low" glucose level.
Halamek
L P
LP
Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Stevenson
D K
DK
D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D007003:Hypoglycemia / Q000151:congenital* / Q000188:drug therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D007262:Infusions, Intravenous; D008403:Mass Screening; D012307:Risk Factors
D005947:Glucose